BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 14701861)

  • 21. PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL.
    di Masi A; Cilli D; Berardinelli F; Talarico A; Pallavicini I; Pennisi R; Leone S; Antoccia A; Noguera NI; Lo-Coco F; Ascenzi P; Minucci S; Nervi C
    Cell Death Dis; 2016 Jul; 7(7):e2308. PubMed ID: 27468685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PML-RARalpha alleviates the transcriptional repression mediated by tumor suppressor Rb.
    Khan MM; Nomura T; Kim H; Kaul SC; Wadhwa R; Zhong S; Pandolfi PP; Ishii S
    J Biol Chem; 2001 Nov; 276(47):43491-4. PubMed ID: 11583987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.
    Li K; Wang F; Cao WB; Lv XX; Hua F; Cui B; Yu JJ; Zhang XW; Shang S; Liu SS; Yu JM; Han MZ; Huang B; Zhang TT; Li X; Jiang JD; Hu ZW
    Cancer Cell; 2017 May; 31(5):697-710.e7. PubMed ID: 28486108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation.
    Wang QQ; Zhou XY; Zhang YF; Bu N; Zhou J; Cao FL; Naranmandura H
    Oncotarget; 2015 Sep; 6(28):25646-59. PubMed ID: 26213848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cells.
    Zheng X; Seshire A; Rüster B; Bug G; Beissert T; Puccetti E; Hoelzer D; Henschler R; Ruthardt M
    Haematologica; 2007 Mar; 92(3):323-31. PubMed ID: 17339181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia.
    Barbarroja N; Siendones E; Torres LA; Luque MJ; Martinez JM; Dorado G; Velasco F; Torres A; López-Pedrera C
    Br J Haematol; 2008 Jul; 142(1):27-35. PubMed ID: 18445086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding.
    Schoofs T; Rohde C; Hebestreit K; Klein HU; Göllner S; Schulze I; Lerdrup M; Dietrich N; Agrawal-Singh S; Witten A; Stoll M; Lengfelder E; Hofmann WK; Schlenke P; Büchner T; Hansen K; Berdel WE; Rosenbauer F; Dugas M; Müller-Tidow C
    Blood; 2013 Jan; 121(1):178-87. PubMed ID: 23152544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutant AF-2 domain of PML-RARalpha in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARalpha and its down-regulation in acute promyelocytic leukemia.
    Kitamura K; Kiyoi H; Yoshida H; Saito H; Ohno R; Naoe T
    Leukemia; 1997 Nov; 11(11):1950-6. PubMed ID: 9369431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PML/RARalpha plays a role for basal activity and retinoid-induced repression of the tissue factor promoter in acute promyelocytic leukemia cells.
    Tenno T; Oberg F; Mackman N; Nilsson K; Siegbahn A
    Thromb Haemost; 2003 Nov; 90(5):930-9. PubMed ID: 14597990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells.
    Moog-Lutz C; Peterson EJ; Lutz PG; Eliason S; Cavé-Riant F; Singer A; Di Gioia Y; Dmowski S; Kamens J; Cayre YE; Koretzky G
    J Biol Chem; 2001 Jun; 276(25):22375-81. PubMed ID: 11301322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia.
    Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL
    Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting PML/RARalpha transcript with DNAzymes results in reduction of proliferation and induction of apoptosis in APL cells.
    Kabuli M; Yin JA; Tobal K
    Hematol J; 2004; 5(5):426-33. PubMed ID: 15448669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PML/RARalpha, a fusion protein in acute promyelocytic leukemia, prevents growth factor withdrawal-induced apoptosis in TF-1 cells.
    Fu S; Consoli U; Hanania EG; Zu Z; Claxton DF; Andreeff M; Deisseroth AB
    Clin Cancer Res; 1995 Jun; 1(6):583-90. PubMed ID: 9816019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cells.
    Jing Y; Xia L; Lu M; Waxman S
    Oncogene; 2003 Jun; 22(26):4083-91. PubMed ID: 12821942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two critical hits for promyelocytic leukemia.
    He LZ; Bhaumik M; Tribioli C; Rego EM; Ivins S; Zelent A; Pandolfi PP
    Mol Cell; 2000 Nov; 6(5):1131-41. PubMed ID: 11106752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skp2 promotes APL progression through the stabilization of oncoprotein PML-RARα and the inhibition of JunB expression.
    Dan W; Zhong L; Yu L; Xiong L; Li J; Ye J; Luo X; Liu C; Chu X; Liu B
    Life Sci; 2022 Jan; 289():120231. PubMed ID: 34921867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of PML-I in reformation of PML nuclear bodies in acute promyelocytic leukemia cells by leptomycin B.
    Wang C; Su L; Shao YM; Chen WZ; Bu N; Hao R; Ma LY; Hussain L; Lu XY; Wang QQ; Naranmandura H
    Toxicol Appl Pharmacol; 2019 Dec; 384():114775. PubMed ID: 31669778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute promyelocytic leukemia: PML/RARalpha and the leukemic stem cell.
    Puccetti E; Ruthardt M
    Leukemia; 2004 Jul; 18(7):1169-75. PubMed ID: 15103387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
    Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
    Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coiled-coil domain of PML is essential for the aberrant dynamics of PML-RARalpha, resulting in sequestration and decreased mobility of SMRT.
    Huang Y; Qiu J; Chen G; Dong S
    Biochem Biophys Res Commun; 2008 Jan; 365(2):258-65. PubMed ID: 17991421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.